Fate Therapeutics
FATE
#9044
Rank
โ‚ฌ0.10 B
Marketcap
0,93ย โ‚ฌ
Share price
-1.82%
Change (1 day)
-58.74%
Change (1 year)

Fate Therapeutics (FATE) Fails to deliver data

Key failure to deliver metrics for Fate Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Fate Therapeutics (FATE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013

Volume in USD (price x number of shares), data since 2013

Fate Therapeutics (FATE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ1.35 M12.52%
2024โ‚ฌ1.2 M-44.15%
2023โ‚ฌ2.15 M-89.19%
2022โ‚ฌ19.92 M-20.28%
2021โ‚ฌ24.99 M31.2%
2020โ‚ฌ19.05 M9.95%
2019โ‚ฌ17.32 M59.52%
2018โ‚ฌ10.86 M1415.4%
2017โ‚ฌ0.71 M181.93%
2016โ‚ฌ0.25 M-79.05%
2015โ‚ฌ1.21 M-17.49%
2014โ‚ฌ1.47 M-81.78%
2013โ‚ฌ8.07 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Sarepta Therapeutics
SRPT
โ‚ฌ2.3 Mโ‚ฌ22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
โ‚ฌ3.56 Mโ‚ฌ85.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
โ‚ฌ3.49 Mโ‚ฌ32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
โ‚ฌ21.53 Mโ‚ฌ35.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ2.71 Mโ‚ฌ30.9 M๐Ÿ‡บ๐Ÿ‡ธ USA